secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2022-11-15T23:59:59+00:00
Accession:  0001140361-22-041531
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SANUWAVE Q3 revenue $4.2M (+12% YoY); gross margin 85%; turns EBITDA positive in October
--------------------------------------------------------------------------------

- Q3 revenue $4.2M, +12% YoY; nine-month revenue $11.2M, +28.5% YoY.
- Gross margin improved to 85% from 58% YoY; nine-month margin 77% vs 58%.
- Operating loss narrowed to $1.8M from $3.4M YoY; nine-month operating expense down 17.6%.
- Company became EBITDA positive in October 2022 and expects Q4 profitability.
- Post-quarter raised ~$2M for sales hiring and inventory; terms consistent with August financing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000114036122041531/0001140361-22-041531-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000114036122041531/brhc10044117_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-22-041531

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer